Mali Bhupesh C, Badgujar Shamkant B, Shukla Kunal K, Bhanushali Paresh B
Laboratory of Native Proteins, Research and Development Division, Yashraj Biotechnology Ltd., Navi Mumbai, 400705 Maharashtra, India.
Laboratory of Native Proteins, Research and Development Division, Yashraj Biotechnology Ltd., Navi Mumbai, 400705 Maharashtra, India.
Int J Biol Macromol. 2017 Feb;95:331-339. doi: 10.1016/j.ijbiomac.2016.11.076. Epub 2016 Nov 22.
We describe a chromatographic approach for the purification of urinary free light chains (FLCs) viz., lambda free light chains (λ-FLCs) and kappa free light chains (κ-FLCs). Isolated urinary FLCs were analyzed by SDS-PAGE, immunoblotting and mass spectrometry (MS). The relative molecular masses of λ-FLC and κ-FLC are 22,933.397 and 23,544.336Da respectively. Moreover, dimer forms of each FLC were also detected in mass spectrum which corresponds to 45,737.747 and 47,348.028Da respectively for λ-FLCs and κ-FLCs. Peptide mass fingerprint analysis of the purified λ-FLCs and κ-FLCs has yielded peptides that partially match with known light chain sequences viz., gi|218783338 and gi|48475432 respectively. The tryptic digestion profile of isolated FLCs infers the exclusive nature of them and they may be additive molecules in the dictionary of urinary proteins. This is the first report of characterization and validation of FLCs from large volume samples by peptide sequencing. This simple and cost-effective approach to purification of FLCs, together with the easy availability of urine samples make the large-scale production of FLCs possible, allowing exploration of various bioclinical as well as biodiagnostic applications.
我们描述了一种用于纯化尿液游离轻链(FLC)的色谱方法,即λ游离轻链(λ-FLC)和κ游离轻链(κ-FLC)。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)、免疫印迹和质谱(MS)对分离出的尿液FLC进行分析。λ-FLC和κ-FLC的相对分子质量分别为22,933.397Da和23,544.336Da。此外,在质谱中还检测到了每种FLC的二聚体形式,λ-FLC和κ-FLC的二聚体形式分别对应于45,737.747Da和47,348.028Da。对纯化后的λ-FLC和κ-FLC进行肽质量指纹分析,得到的肽段与已知轻链序列分别部分匹配,即gi|218783338和gi|48475432。分离出的FLC的胰蛋白酶消化图谱表明它们具有独特性,并且它们可能是尿液蛋白质库中的附加分子。这是首次通过肽测序对大量样品中的FLC进行表征和验证的报告。这种简单且经济高效的FLC纯化方法,再加上尿液样品易于获取,使得大规模生产FLC成为可能,从而能够探索各种生物临床以及生物诊断应用。